Filius Bart
SEC CIK 2115417 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PRQR | ProQR Therapeutics N.V. | Dir | 300.0K | $488.9K | — | 2 | 2026-06-26 | 2026-07-17 |
Most active insiders at PRQR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | de Boer Daniel Anton | CEO, Dir | $853.5K | — |
| 2 | Filius Bart | Dir | $488.9K | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-21 08:00 | 2026-07-17 | PRQR | ProQR Therapeutics N.V. | Filius Bart | Dir | P - Purchase | $1.72 | +150.0K | 300.0K | +100% | +$257.9K | |
| 2026-06-30 16:01 | 2026-06-26 | PRQR | ProQR Therapeutics N.V. | Filius Bart | Dir | P - Purchase | $1.54 | +150.0K | 150.0K | New | +$231.0K |
Purchase Sale Sale after option exercise All abbreviations